BCG vaccination alters the epigenetic landscape of progenitor cells in human bone marrow to influence innate immune responses

Sarah J. Sun,Raúl Aguirre-Gamboa,L. Charlotte J. de Bree,Joaquin Sanz,Anne Dumaine,Walter J.F.M. van der Velden,Leo A.B. Joosten,Shabaana Khader,Maziar Divangahi,Mihai G. Netea,Luis B. Barreiro

DOI: https://doi.org/10.1016/j.immuni.2024.07.021

IF: 32.4

2024-09-11

Immunity

Abstract:The BCG vaccine for tuberculosis protects against non-mycobacterial infections, but the mechanisms are unclear. Sun et al. found that BCG alters gene expression and chromatin accessibility in hematopoietic stem and progenitor cells (HSPCs), predicting cytokine secretion in peripheral blood mononuclear cells. This research highlights BCG's lasting, multimodal effects on HSPCs and the regulation of innate immune responses.

immunology